Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DWP450 vs Botox for Glabellar Lines
NCT01629875Phase 3Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Mar 2012
- Primary completion
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of prabotulinumtoxinA in glabellar lines, sponsored by Daewoong Pharmaceutical. Started Mar 2012; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT01629875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629875.